Vycor Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-72.4K | $-107.2K | $-69.7K | $-404.9K | $-435.7K | $-822.5K | $-796.2K | $-1.4M |
| Depreciation & Amortization | $59.5K | $59.5K | $57.5K | $58.2K | $66.1K | $56.5K | $59.9K | $166.4K |
| Depreciation | $63.1K | $63.9K | $60.8K | $61.4K | $57.1K | $45.9K | $49.5K | $127.0K |
| Amortization | — | — | — | — | $11.3K | $12.0K | $12.2K | $50.3K |
| Stock-Based Compensation | $48.8K | $26.8K | $10.1K | $185.6K | $341.1K | $520.0K | $534.9K | $625.6K |
| Net Cash from Operating Activities | $-13.5K | $60.1K | $29.4K | $-217.0K | $21.4K | $-248.8K | $-6.0K | $-260.3K |
| Investing Activities | ||||||||
| Capital Expenditures | $5.2K | $5.4K | $9.4K | $2.8K | $38.4K | $62.1K | $52.9K | $63.5K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-4.4K | $-4.2K | $-9.4K | $-2.8K | $-38.4K | $-52.5K | $-50.4K | $-63.5K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-812 | $-7.6K | $211 | $165.9K | $61.9K | $286.6K | $40.1K | $200.4K |
| Net Change in Cash | $-18.7K | $48.4K | $20.3K | $-53.9K | $44.9K | $-14.7K | $-17.3K | $-119.7K |
| Free Cash Flow | $-18.7K | $54.7K | $20.0K | $-219.8K | $-17.0K | $-310.8K | $-58.9K | $-323.8K |